Financial Health Assessment: SSQC LTD

1. Financial Health Score: F (Terminal / Inactive)

Explanation: The patient has passed away, though not from natural causes or disease. The latest filed accounts explicitly state that the company "ceased trading on 31 December 2025 and is being wound up." The 2026 financial history shows a complete flatline (£0 across all metrics), and the company status is listed as Dissolved. While the business was financially healthy during its operational life, its current condition is terminal by design.

2. Key Vital Signs

• Pulse (Liquidity & Cash Flow): Flatline. The most recent balance sheet for the year ending 31 March 2026 shows £0 in total assets, liabilities, and net assets. The heart of the business has stopped pumping.
• Blood Pressure (Solvency): Historically robust. In its final full year of trading (2025), the company maintained strong blood pressure with £478,213 in total assets and £417,432 in net assets. There were no symptoms of over-indebtedness or insolvency prior to closure.
• Temperature (Growth & Vitality): Cooling down naturally. Looking at the historical data, the company experienced a healthy metabolism. Net assets grew steadily from £119,186 in 2020 to a peak of £497,009 in 2023. A slight reduction in reserves in 2024 and 2025 (£453k and £417k respectively) was likely a symptom of the planned wind-down rather than a sudden fever.
• Organ Function (Operations): Ceased. The company employed 11 people in its final year (up from 10 in 2024), indicating it was functioning normally right up until the decision to cease trading was executed.

3. Diagnosis

This is a case of planned retirement rather than a sudden medical emergency. The financial data reveals a business that was fundamentally sound and healthy right up until the end of its life.

The company, formerly known as Shetland Seafood Quality Control Limited, operated successfully for over 25 years (incorporated in 2000). The steady accumulation of net assets over the last decade indicates a profitable, self-sustaining organism. The decision to cease trading on 31 December 2025 and enter a winding-up process appears to be a strategic or lifecycle decision by the directors, not a forced closure due to financial distress. The zeroing out of the balance sheet in 2026 is simply the final administrative heartbeat of the dissolution process, where remaining assets and liabilities are settled.

4. Recommendations

Because the "patient" is already in the process of dissolution, traditional financial wellness recommendations do not apply. Instead, these are post-mortem recommendations for the directors and stakeholders:

• Complete the Final Paperwork: Ensure all final distributions are correctly processed and that Companies House has received all necessary documentation to finalize the dissolution smoothly without administrative penalties.
• Asset Distribution: As a company limited by guarantee (often used for non-profits, community interest, or professional bodies), ensure any remaining surplus assets are distributed strictly in accordance with the company's constitution or articles of association (e.g., transferred to a similar organization rather than distributed as profit).
• Preserve Institutional Knowledge: The company demonstrated strong financial stewardship over its lifetime. Directors should carry the lessons learned from this healthy operational history into any future ventures or appointments.